Protocol for a feasibility randomized controlled trial to evaluate the efficacy, safety and tolerability of N-acetylcysteine in reducing adverse drug reactions among adults treated for multidrug-resistant tuberculosis in Tanzania.
Stellah G MpagamaHappiness C MvungiPeter M MbeleleHadija H SemvuaAlphonce A LiyoyoKristen Petros de GuexDerek SloanGibson S KibikiMartin BoereePatrick P J PhillipsScott K HeysellPublished in: Pilot and feasibility studies (2023)
PACTR202007736854169 Registered 03 July 2020.
Keyphrases
- adverse drug
- randomized controlled trial
- multidrug resistant
- study protocol
- drug resistant
- acinetobacter baumannii
- gram negative
- open label
- electronic health record
- emergency department
- drug induced
- mycobacterium tuberculosis
- clinical trial
- systematic review
- double blind
- meta analyses
- escherichia coli
- hiv infected
- pseudomonas aeruginosa
- cystic fibrosis
- hepatitis c virus